Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial Phase IIa, on Amelioration of Decompensated Liver Cirrhosis With Mesenchymal Stem Cells-derived Exosomes

NCT05871463 is registered in ClinicalTrials.gov with Research Institute for Gastroenterology and Liver Diseases (RIGLD) as lead sponsor.

NCT NCT05871463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05871463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial Phase IIa, on Amelioration of Decompensated Liver Cirrhosis With Mesenchymal Stem Cells-derived Exosomes
Lead sponsor
Research Institute for Gastroenterology and Liver Diseases (RIGLD)
Phase
Phase 2
Overall status
Unknown status
Start date
May 26, 2023
Completion date
December 11, 2023
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

decompensated liver cirrhosis